- Home
- CURV vs OLMA Comparison
CURV vs OLMA Comparison
Compare CURV & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURV
- OLMA
- Stock Information
- Founded
- CURV 2001
- OLMA 2006
- Country
- CURV United States
- OLMA United States
- Employees
- CURV N/A
- OLMA N/A
- Industry
- CURV Clothing/Shoe/Accessory Stores
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- CURV Consumer Discretionary
- OLMA Health Care
- Exchange
- CURV Nasdaq
- OLMA Nasdaq
- Market Cap
- CURV 402.0M
- OLMA 420.2M
- IPO Year
- CURV 2021
- OLMA 2020
- Fundamental
- Price
- CURV $6.27
- OLMA $5.50
- Analyst Decision
- CURV Hold
- OLMA Strong Buy
- Analyst Count
- CURV 5
- OLMA 5
- Target Price
- CURV $5.00
- OLMA $26.25
- AVG Volume (30 Days)
- CURV 406.5K
- OLMA 1.3M
- Earning Date
- CURV 12-03-2024
- OLMA 03-10-2025
- Dividend Yield
- CURV N/A
- OLMA N/A
- EPS Growth
- CURV 29.45
- OLMA N/A
- EPS
- CURV 0.14
- OLMA N/A
- Revenue
- CURV $1,121,714,000.00
- OLMA N/A
- Revenue This Year
- CURV N/A
- OLMA N/A
- Revenue Next Year
- CURV $0.45
- OLMA N/A
- P/E Ratio
- CURV $44.61
- OLMA N/A
- Revenue Growth
- CURV N/A
- OLMA N/A
- 52 Week Low
- CURV $2.18
- OLMA $4.60
- 52 Week High
- CURV $9.14
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- CURV 75.86
- OLMA 40.52
- Support Level
- CURV $5.46
- OLMA $4.60
- Resistance Level
- CURV $6.00
- OLMA $5.83
- Average True Range (ATR)
- CURV 0.38
- OLMA 0.55
- MACD
- CURV 0.04
- OLMA 0.16
- Stochastic Oscillator
- CURV 80.89
- OLMA 58.06
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America targeting 27 to 42-year-old women. It is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of e-Commerce platform and stores.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.